000			01971 a2200541 4500
005			20250516212946.0
264		0	_c20150511
008			201505s 0 0 eng d
022			_a1095-953X
024	7		_a10.1016/j.nbd.2014.04.021 _2doi
040			_aNLM _beng _cNLM
100	1		_aChou, Jun-Shiao
245	0	0	_a(G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse. _h[electronic resource]
260			_bNeurobiology of disease _cAug 2014
300			_a190-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApomorphine _xpharmacology
650	0	4	_aCerebral Cortex _xphysiopathology
650	0	4	_aCorpus Striatum _xphysiopathology
650	0	4	_aDopamine Agonists _xpharmacology
650	0	4	_aDopaminergic Neurons _xphysiology
650	0	4	_aGABA Antagonists _xpharmacology
650	0	4	_aGlycine _xgenetics
650	0	4	_aHumans
650	0	4	_aLeucine-Rich Repeat Serine-Threonine Protein Kinase-2
650	0	4	_aLong-Term Potentiation _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aMotor Activity _xgenetics
650	0	4	_aMutation _xgenetics
650	0	4	_aParkinson Disease _xgenetics
650	0	4	_aPicrotoxin _xpharmacology
650	0	4	_aProtein Serine-Threonine Kinases _xgenetics
650	0	4	_aRadionuclide Imaging
650	0	4	_aSerine _xgenetics
650	0	4	_aSubstantia Nigra _xdiagnostic imaging
650	0	4	_aTyrosine 3-Monooxygenase _xmetabolism
700	1		_aChen, Chu-Yu
700	1		_aChen, Ying-Ling
700	1		_aWeng, Yi-Hsin
700	1		_aYeh, Tu-Hsueh
700	1		_aLu, Chin-Song
700	1		_aChang, Ya-Ming
700	1		_aWang, Hung-Li
773	0		_tNeurobiology of disease _gvol. 68 _gp. 190-9
856	4	0	_uhttps://doi.org/10.1016/j.nbd.2014.04.021 _zAvailable from publisher's website
999			_c23827506 _d23827506